Oxford Martin Senior Alumni Fellow
Sarah Gilbert was a Principal Investigator in the Oxford Martin Programme on Vaccines, which was part of the Oxford Martin School from 2010-2015.
Professor Gilbert’s chief research interest is the development of vaccines that work by inducing strong and protective T cell responses. Following the discovery that heterologous prime-boost immunisation, in which the same antigen is delivered in first one vector and then another, is highly immunogenic in pre-clinical studies, she designed antigen inserts for, and produced DNA, MVA and fowlpox vaccines which were then manufactured for clinical trials in both the malaria and tuberculosis vaccine clinical programmes. More recently Dr Gilbert has begun to apply the same principles of vaccine development, pre-clinical and clinical testing to new vaccines against influenza, and now leads this Jenner Institute programme.